Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-J Milloy

Showing results (1-10 of 325) with videos related to

Pageof 33
Sort By:
Addiction (Abingdon, England)|April 2, 2009
Emerging role of supervised injecting facilities in human immunodeficiency virus preventionM-J Milloy, Evan Wood
Lancet (London, England)|June 2, 2015
Withdrawal from methadone in US prisons: cruel and unusual?M-J Milloy, Evan Wood
Addiction (Abingdon, England)|June 9, 2018
Access to medical cannabis is expanding across North America regardless of the opioid crisis-why not study if it could help?Stephanie Lake, M-J Milloy
The Lancet. Infectious Diseases|May 3, 2011
Transmitted antiretroviral-resistant HIV: a coming anarchy?M-J Milloy, Evan Wood
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 24, 2011
Collateral consequences of an ever-expanding prison systemStuart A Kinner, M-J Milloy
Current Infectious Disease Reports|August 2, 2018
Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is UnknownM Eugenia Socias, M-J Milloy
The International Journal on Drug Policy|July 10, 2020
Ranking evidence in substance use and addictionHudson Reddon, Thomas Kerr, M-J Milloy
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 21, 2011
Ending Canada's HIV trialsM-J Milloy, Thomas Kerr, Julio Montaner
Addiction (Abingdon, England)|October 13, 2016
Improving the effectiveness and delivery of pre-exposure prophylaxis (PrEP) to people who inject drugsBrandon D L Marshall, M-J Milloy
JAMA Internal Medicine|May 6, 2024
Examining Safer Opioid Supply PoliciesHudson Reddon, Paxton Bach, M-J Milloy
Pageof 33

Showing results (1-10 of 325) with videos related to

Sort By:
Pageof 33
Addiction (Abingdon, England)|April 2, 2009
Emerging role of supervised injecting facilities in human immunodeficiency virus preventionM-J Milloy, Evan Wood
Lancet (London, England)|June 2, 2015
Withdrawal from methadone in US prisons: cruel and unusual?M-J Milloy, Evan Wood
Addiction (Abingdon, England)|June 9, 2018
Access to medical cannabis is expanding across North America regardless of the opioid crisis-why not study if it could help?Stephanie Lake, M-J Milloy
The Lancet. Infectious Diseases|May 3, 2011
Transmitted antiretroviral-resistant HIV: a coming anarchy?M-J Milloy, Evan Wood
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 24, 2011
Collateral consequences of an ever-expanding prison systemStuart A Kinner, M-J Milloy
Current Infectious Disease Reports|August 2, 2018
Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is UnknownM Eugenia Socias, M-J Milloy
The International Journal on Drug Policy|July 10, 2020
Ranking evidence in substance use and addictionHudson Reddon, Thomas Kerr, M-J Milloy
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|December 21, 2011
Ending Canada's HIV trialsM-J Milloy, Thomas Kerr, Julio Montaner
Addiction (Abingdon, England)|October 13, 2016
Improving the effectiveness and delivery of pre-exposure prophylaxis (PrEP) to people who inject drugsBrandon D L Marshall, M-J Milloy
JAMA Internal Medicine|May 6, 2024
Examining Safer Opioid Supply PoliciesHudson Reddon, Paxton Bach, M-J Milloy
Pageof 33